According to studies conducted in vivo and in vitro, luteolin can treat sepsis through the destabilization of the heat-shock protein 90 (Hsp90), which destabilizes c-Jun and Akt, thus decreasing the release of HMGB1 and its activation of the inflammatory cascade [147]. Here, HMGB1 is linked to Sepsis.